Médecine thérapeutique / Pédiatrie
MENUThe application of magnetic resonance spectroscopy in neuropaediatrics Volume 16, issue 3, Juillet-Août-Septembre 2013
Figures
CHU de Bordeaux,
hôpital Pellegrin,
service d’imagerie anténatale, de l’enfant et de la femme,
place A.-Raba-Léon,
33076 Bordeaux,
France, CNRS-université de Bordeaux,
CNRS-RMSB,
UMR 5536,
33000 Bordeaux,
France
- Key words: child, magnetic resonance spectroscopy, brain hypoxia, metabolic disease, brain tumour
- DOI : 10.1684/mtp.2013.0485
- Page(s) : 212-28
- Published in: 2013
Magnetic resonance spectroscopy (MRS) is a technique that complements MRI in the study of brain diseases. Currently, most systems using ≥1.5 T can be used to perform MRS. Following a theoretical overview, the details of modes of acquisition and spectral analysis, in particular, for hydrogen proton spectroscopy, are presented. The main applications are: (1) anoxic-ischaemic injury, particularly in the newborn; (2) degenerative and metabolic diseases; and (3) diagnosis and treatment of brain tumours.